Skip to content
healthcare.dev

Palonosetron

NDC 67184-0515, Palonosetron Hydrochloride, injection, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0515
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205648
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0515 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALONOSETRON HYDROCHLORIDE.075 mg/1.5mL

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
67184-0515-2671840515025 VIAL in 1 CARTON (67184-0515-2) / 1.5 mL in 1 VIAL (67184-0515-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/633abdc2-a942-4eb2-a0f8-f9f4e727211e

Use it

Look up 67184-0515 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0515 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.